Insider Selling: Arteris (NASDAQ:AIP) Major Shareholder Sells $2,216,820.00 in Stock

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 73,894 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $30.00, for a total value of $2,216,820.00. Following the transaction, the insider directly owned 8,355,177 shares in the company, valued at approximately $250,655,310. This trade represents a 0.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Tuesday, August 4th, Bayview Legacy, Llc sold 26,106 shares of Arteris stock. The stock was sold at an average price of $31.97, for a total value of $834,608.82.
• On Monday, July 6th, Bayview Legacy, Llc sold 125,976 shares of Arteris stock. The shares were sold at an average price of $35.79, for a total value of $4,508,681.04.
• On Thursday, July 2nd, Bayview Legacy, Llc sold 192,686 shares of Arteris stock. The shares were sold at an average price of $36.32, for a total value of $6,998,355.52.
• On Monday, June 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The stock was sold at an average price of $34.91, for a total value of $2,443,700.00.
• On Friday, May 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The stock was sold at an average price of $31.20, for a total value of $2,184,000.00.

Arteris Price Performance

Shares of AIP opened at $29.78 on Friday. The business’s fifty day moving average is $35.94 and its 200 day moving average is $26.19. Arteris, Inc. has a 12-month low of $8.42 and a 12-month high of $50.26. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The stock has a market cap of $1.37 billion, a P/E ratio of -34.23 and a beta of 1.96.

Arteris (NASDAQ:AIP) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The business had revenue of $24.13 million for the quarter, compared to analyst estimates of $23.48 million. Sell-side analysts anticipate that Arteris, Inc. will post -0.58 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on AIP shares. TD Cowen upped their target price on shares of Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Roth Capital began coverage on Arteris in a research note on Tuesday. They set a “buy” rating and a $40.00 price target for the company. Northland Securities set a $38.00 price objective on Arteris in a research note on Wednesday, May 13th. Oppenheimer assumed coverage on Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 target price on the stock. Finally, Wall Street Zen cut Arteris from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Five research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $41.00.

Arteris News Summary

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Jefferies upgraded Arteris from Hold to Buy and assigned a $50 price target, indicating substantial potential upside. Jefferies upgrade
• Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and raised or maintained a $38 price target, while Roth Capital also initiated coverage with a Buy rating and a $40 target. The endorsements strengthen the bullish analyst backdrop for AIP. Rosenblatt rating Roth Capital rating
• Positive Sentiment: Arteris projected third-quarter revenue of $24 million to $25 million and updated full-year 2026 revenue guidance to $95 million to $98 million. Both ranges exceed consensus estimates of approximately $23.5 million and $94.2 million, respectively. Arteris results and guidance
• Neutral Sentiment: The company appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, but investors may initially monitor the transition. CFO appointment
• Negative Sentiment: Second-quarter adjusted results showed a loss of $0.10 per share, worse than the expected loss of roughly $0.04-$0.05. Revenue of $24.13 million exceeded estimates, but the larger-than-expected loss likely drove selling pressure. Arteris second-quarter results
• Negative Sentiment: Recent filings disclosed sales by CEO K. Charles Janac, director Saiyed Atiq Raza, major shareholder Bayview Legacy and Vice President Paul Alpern. The concentration of insider selling may weigh on sentiment, although insiders retain significant positions.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in AIP. Versant Capital Management Inc grew its stake in Arteris by 33.7% in the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after purchasing an additional 290 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Arteris during the 2nd quarter worth $53,000. Intech Investment Management LLC raised its stake in shares of Arteris by 9.3% during the 4th quarter. Intech Investment Management LLC now owns 13,540 shares of the company’s stock worth $210,000 after purchasing an additional 1,148 shares during the period. Deutsche Bank AG boosted its holdings in shares of Arteris by 7.7% in the 4th quarter. Deutsche Bank AG now owns 21,159 shares of the company’s stock worth $328,000 after buying an additional 1,504 shares during the last quarter. Finally, BNP Paribas Financial Markets boosted its holdings in shares of Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock worth $61,000 after buying an additional 2,595 shares during the last quarter. 64.36% of the stock is owned by institutional investors.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.